TY - JOUR
KW - Adult
KW - Animals
KW - Anti-Inflammatory Agents, Non-Steroidal
KW - Antifibrinolytic Agents
KW - Behcet Syndrome
KW - Child
KW - Child, Preschool
KW - Graft vs Host Disease
KW - Hemorheology
KW - HIV Infections
KW - Humans
KW - Infant
KW - Leishmaniasis, Cutaneous
KW - leprosy
KW - Mice
KW - Mice, Nude
KW - Pentoxifylline
KW - Phosphodiesterase Inhibitors
KW - Sarcoidosis
KW - Skin Diseases
KW - Tumor Necrosis Factor-alpha
KW - Vascular Diseases
AU - Zargari O
AB - <p>Pentoxifylline (PTX) is a methylxanthine derivative with a variety of anti-inflammatory effects. Currently, PTX is approved by the Food and Drug Administration for the treatment of intermittent claudication, but studies have shown that it has a variety of physiological effects at the cellular level, which may be important in treating a diverse group of diseases.</p>
BT - Dermatology online journal
C1 - http://www.ncbi.nlm.nih.gov/pubmed/19094840?dopt=Abstract
DA - 2008 Nov 15
IS - 11
J2 - Dermatol. Online J.
LA - eng
N2 - <p>Pentoxifylline (PTX) is a methylxanthine derivative with a variety of anti-inflammatory effects. Currently, PTX is approved by the Food and Drug Administration for the treatment of intermittent claudication, but studies have shown that it has a variety of physiological effects at the cellular level, which may be important in treating a diverse group of diseases.</p>
PY - 2008
EP - 2
T2 - Dermatology online journal
TI - Pentoxifylline: a drug with wide spectrum applications in dermatology.
VL - 14
SN - 1087-2108
ER -